REVANCE THERAPEUTICS Trademark

Trademark Overview


On Tuesday, August 3, 2021, a trademark application was filed for REVANCE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the REVANCE THERAPEUTICS trademark a serial number of 90862492. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, August 13, 2024. This trademark is owned by Revance Therapeutics, Inc.. The REVANCE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, rosacea and other skin conditions, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes; Dermatological pharmaceutical products and pharmaceutical preparations injected into or under the skin, into or under mucous membranes for filling in wrinkles, skin depressions for remodeling, increasing volume in the face or any ot...
revance therapeutics

General Information


Serial Number90862492
Word MarkREVANCE THERAPEUTICS
Filing DateTuesday, August 3, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, August 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, rosacea and other skin conditions, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes; Dermatological pharmaceutical products and pharmaceutical preparations injected into or under the skin, into or under mucous membranes for filling in wrinkles, skin depressions for remodeling, increasing volume in the face or any other part of the body, for moisturizing the skin or mucous membranes, for increasing lip volume
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRevance Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Party NameRevance Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Trademark Events


Event DateEvent Description
Tuesday, November 16, 2021EXAMINERS AMENDMENT E-MAILED
Friday, August 6, 2021NEW APPLICATION ENTERED
Tuesday, September 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 15, 2021ASSIGNED TO EXAMINER
Tuesday, November 16, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 16, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 16, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, November 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 3, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 14, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 3, 2022SOU EXTENSION 1 FILED
Wednesday, August 3, 2022SOU EXTENSION 1 GRANTED
Friday, August 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 14, 2023SOU EXTENSION 2 FILED
Tuesday, February 14, 2023SOU EXTENSION 2 GRANTED
Monday, August 14, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 14, 2023SOU EXTENSION 3 FILED
Monday, August 14, 2023SOU EXTENSION 3 GRANTED
Wednesday, August 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 14, 2024SOU EXTENSION 4 GRANTED
Wednesday, February 14, 2024SOU EXTENSION 4 FILED
Wednesday, February 14, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2024SOU EXTENSION 5 FILED
Tuesday, August 13, 2024SOU EXTENSION 5 GRANTED